{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:56:49Z","timestamp":1791219409606,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K08AI132739"],"award-info":[{"award-number":["K08AI132739"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017922","name":"Potts Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017922","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TRBU Network","award":["U19 AI11143"],"award-info":[{"award-number":["U19 AI11143"]}]},{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98367-4","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:02:00Z","timestamp":1745938920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["CD8\u03b1 marks a Mycobacterium tuberculosis-reactive human NK cell population with high activation potential"],"prefix":"10.1038","volume":"15","author":[{"given":"Nezar","family":"Mehanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodota","family":"Kontopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Kong V.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Benoit","family":"Le Luduec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Kyriakos","family":"Vorkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"10","key":"98367_CR1","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben, R. M. & Dodd, P. J. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Med. 13 (10), e1002152 (2016).","journal-title":"PLoS Med."},{"issue":"1","key":"98367_CR2","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi, S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe 4 (1), e20 (2023).","journal-title":"Lancet Microbe"},{"issue":"6","key":"98367_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S2213-2600(24)00028-6","volume":"12","author":"AK Coussens","year":"2024","unstructured":"Coussens, A. K. et al. Classification of early tuberculosis states to guide research for improved care and prevention: An international Delphi consensus exercise. Lancet Respir. Med. 12 (6), 484\u2013498 (2024).","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"98367_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/aje\/kwt246","volume":"179","author":"KM Shea","year":"2014","unstructured":"Shea, K. M. et al. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am. J. Epidemiol. 179 (2), 216\u2013225 (2014).","journal-title":"Am. J. Epidemiol."},{"issue":"12","key":"98367_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","volume":"7","author":"III Barry","year":"2009","unstructured":"Barry, I. I. I. The spectrum of latent tuberculosis: Rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7 (12), 845\u2013855 (2009).","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"98367_CR6","first-page":"1342","volume":"221","author":"AJ Verrall","year":"2020","unstructured":"Verrall, A. J. et al. Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses. J. Infect. Dis. 221 (8), 1342\u20131350 (2020).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"98367_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/mi.2011.10","volume":"4","author":"KB Urdahl","year":"2011","unstructured":"Urdahl, K. B., Shafiani, S. & Ernst, J. D. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol. 4 (3), 288\u2013293 (2011).","journal-title":"Mucosal Immunol."},{"issue":"2","key":"98367_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","volume":"379","author":"E Nemes","year":"2018","unstructured":"Nemes, E. et al. Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination. N. Engl. J. Med. 379 (2), 138\u2013149 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"98367_CR9","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","volume":"381","author":"DR Tait","year":"2019","unstructured":"Tait, D. R. et al. Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis. N. Engl. J. Med. 381 (25), 2429\u20132439 (2019).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"98367_CR10","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41590-021-00933-1","volume":"22","author":"A Nathan","year":"2021","unstructured":"Nathan, A. et al. Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease. Nat. Immunol. 22 (6), 781\u2013793 (2021).","journal-title":"Nat. Immunol."},{"issue":"3","key":"98367_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.chom.2023.02.003","volume":"31","author":"A Pradhan","year":"2023","unstructured":"Pradhan, A. & Vorkas, C. K. T cells target TB. Cell. Host Microbe. 31 (3), 329\u2013330 (2023).","journal-title":"Cell. Host Microbe"},{"issue":"5","key":"98367_CR12","doi-asserted-by":"publisher","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","volume":"7","author":"AM Gallegos","year":"2011","unstructured":"Gallegos, A. M. et al. A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo. PLoS Pathog. 7 (5), e1002052 (2011).","journal-title":"PLoS Pathog"},{"key":"98367_CR13","doi-asserted-by":"crossref","unstructured":"Sakai, S. et al. CD4 T cell-derived IFN-gamma plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease. PLoS Pathog. 12 (5) (2016).","DOI":"10.1371\/journal.ppat.1005667"},{"issue":"4","key":"98367_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/trstmh\/trw016","volume":"110","author":"HA Fletcher","year":"2016","unstructured":"Fletcher, H. A. & Schrager, L. TB vaccine development and the end TB strategy: Importance and current status. Trans. R. Soc. Trop. Med. Hyg. 110 (4), 212\u2013218 (2016).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"98367_CR15","doi-asserted-by":"publisher","first-page":"p199","DOI":"10.12688\/f1000research.13588.1","volume":"7","author":"G Voss","year":"2018","unstructured":"Voss, G. et al. Progress and challenges in TB vaccine development. F1000Res 7, p199 (2018).","journal-title":"F1000Res"},{"issue":"1","key":"98367_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.chom.2018.06.004","volume":"24","author":"JD Ernst","year":"2018","unstructured":"Ernst, J. D. Mechanisms of M. tuberculosis immune evasion as challenges to TB vaccine design. Cell. Host Microbe. 24 (1), 34\u201342 (2018).","journal-title":"Cell. Host Microbe"},{"key":"98367_CR17","doi-asserted-by":"publisher","first-page":"102040","DOI":"10.1016\/j.tube.2020.102040","volume":"126","author":"D Roordink","year":"2021","unstructured":"Roordink, D. et al. The TB vaccine development pathway\u2014An innovative approach to accelerating global TB vaccine development. Tuberculosis 126, 102040 (2021).","journal-title":"Tuberculosis"},{"key":"98367_CR18","doi-asserted-by":"crossref","unstructured":"Vorkas, C. K. et al. Mucosal-associated invariant and gammadelta T cell subsets respond to initial Mycobacterium tuberculosis infection. JCI Insight 3 (19) (2018).","DOI":"10.1172\/jci.insight.121899"},{"key":"98367_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fimmu.2020.00226","volume":"11","author":"JA Choreno-Parra","year":"2020","unstructured":"Choreno-Parra, J. A. et al. Thinking outside the box: Innate- and B cell-memory responses as novel protective mechanisms against tuberculosis. Front. Immunol. 11, 226 (2020).","journal-title":"Front. Immunol."},{"issue":"9","key":"98367_CR20","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1172\/JCI128877","volume":"129","author":"SA Khader","year":"2019","unstructured":"Khader, S. A. et al. Targeting innate immunity for tuberculosis vaccination. J. Clin. Investig. 129 (9), 3482\u20133491 (2019).","journal-title":"J. Clin. Investig"},{"key":"98367_CR21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3389\/fimmu.2017.00967","volume":"8","author":"JA Chore\u00f1o Parra","year":"2017","unstructured":"Chore\u00f1o Parra, J. A. et al. Memory of natural killer cells: A new chance against Mycobacterium tuberculosis? Front. Immunol. 8, 967 (2017).","journal-title":"Front. Immunol."},{"issue":"4","key":"98367_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/cells13040293","volume":"13","author":"M Shekarkar Azgomi","year":"2024","unstructured":"Shekarkar Azgomi, M. et al. Integrated analysis of single-cell and bulk RNA sequencing data reveals memory-like NK cell subset associated with Mycobacterium tuberculosis latency. Cells 13 (4), 293 (2024).","journal-title":"Cells"},{"issue":"7534","key":"98367_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517 (7534), 293\u2013301 (2015).","journal-title":"Nature"},{"issue":"4","key":"98367_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","volume":"180","author":"P Dogra","year":"2020","unstructured":"Dogra, P. et al. Tissue determinants of human NK cell development, function, and residence. Cell 180 (4), 749\u2013763e13 (2020).","journal-title":"Cell"},{"issue":"3","key":"98367_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0952-7915(03)00039-6","volume":"15","author":"LL Lanier","year":"2003","unstructured":"Lanier, L. L. Natural killer cell receptor signaling. Curr. Opin. Immunol. 15 (3), 308\u2013314 (2003).","journal-title":"Curr. Opin. Immunol."},{"issue":"11","key":"98367_CR26","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1128\/IAI.00381-07","volume":"75","author":"P Schierloh","year":"2007","unstructured":"Schierloh, P. et al. Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving Toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy. Infect. Immun. 75 (11), 5325\u20135337 (2007).","journal-title":"Infect. Immun."},{"issue":"4","key":"98367_CR27","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/mi.2016.105","volume":"10","author":"S Venkatasubramanian","year":"2017","unstructured":"Venkatasubramanian, S. et al. IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis. Mucosal Immunol. 10 (4), 1031\u20131042 (2017).","journal-title":"Mucosal Immunol."},{"issue":"1","key":"98367_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000363321","volume":"7","author":"S Esin","year":"2015","unstructured":"Esin, S. & Batoni, G. Natural killer cells: A coherent model for their functional role in Mycobacterium tuberculosis infection. J. Innate Immun. 7 (1), 11\u201324 (2015).","journal-title":"J. Innate Immun."},{"key":"98367_CR29","first-page":"1800","volume":"10","author":"CBW Giacoia-Gripp","year":"2019","unstructured":"Giacoia-Gripp, C. B. W. et al. Changes in the NK cell repertoire related to initiation of TB treatment and onset of immune reconstitution inflammatory syndrome in TB\/HIV co-infected patients in Rio de Janeiro, Brazil-ANRS 12274. Front.  Immunol 10, 1800 (2019).","journal-title":"Immunol"},{"key":"98367_CR30","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2015.00508","volume":"6","author":"M Allen","year":"2015","unstructured":"Allen, M. et al. Mechanisms of control of Mycobacterium tuberculosis by NK cells: Role of glutathione. Front. Immunol. 6, 508 (2015).","journal-title":"Front. Immunol."},{"key":"98367_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2018.00257","volume":"9","author":"M Garand","year":"2018","unstructured":"Garand, M. et al. Functional and phenotypic changes of natural killer cells in whole blood during Mycobacterium tuberculosis infection and disease. Front. Immunol. 9, 257 (2018).","journal-title":"Front. Immunol."},{"key":"98367_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fcimb.2020.00120","volume":"10","author":"LD Harris","year":"2020","unstructured":"Harris, L. D. et al. Distinct human NK cell phenotypes and functional responses to Mycobacterium tuberculosis in adults from TB endemic and non-endemic regions. Front. Cell. Infect. Microbiol. 10, 120 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"98367_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-3083.2005.01692.x","volume":"62","author":"G Batoni","year":"2005","unstructured":"Batoni, G. et al. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin. Scand. J. Immunol. 62 (6), 498\u2013506 (2005).","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"98367_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/sji.12052","volume":"77","author":"S Esin","year":"2013","unstructured":"Esin, S. et al. Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2. Scand. J. Immunol. 77 (6), 460\u2013469 (2013).","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"98367_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2567.2004.01858.x","volume":"112","author":"S Esin","year":"2004","unstructured":"Esin, S. et al. Functional characterization of human natural killer cells responding to Mycobacterium bovis Bacille Calmette-Gu\u00e9rin. Immunology 112 (1), 143\u2013152 (2004).","journal-title":"Immunology"},{"issue":"7","key":"98367_CR36","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.4049\/jimmunol.175.7.4611","volume":"175","author":"R Vankayalapati","year":"2005","unstructured":"Vankayalapati, R. et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175 (7), 4611\u20134617 (2005).","journal-title":"J. Immunol."},{"issue":"7","key":"98367_CR37","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.4049\/jimmunol.168.7.3451","volume":"168","author":"R Vankayalapati","year":"2002","unstructured":"Vankayalapati, R. et al. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 168 (7), 3451\u20133457 (2002).","journal-title":"J. Immunol."},{"issue":"11","key":"98367_CR38","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1111\/j.1462-5822.2012.01834.x","volume":"14","author":"D Portevin","year":"2012","unstructured":"Portevin, D. et al. Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype. Cell. Microbiol. 14 (11), 1734\u20131744 (2012).","journal-title":"Cell. Microbiol."},{"key":"98367_CR39","doi-asserted-by":"crossref","unstructured":"Tripathi, D. et al. Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection. JCI Insight 7 (22) (2022).","DOI":"10.1172\/jci.insight.152357"},{"issue":"3","key":"98367_CR40","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1182\/blood.V89.3.910","volume":"89","author":"ME Ross","year":"1997","unstructured":"Ross, M. E. & Caligiuri, M. A. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89 (3), 910\u2013918 (1997).","journal-title":"Blood"},{"issue":"4","key":"98367_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.180.4.1395","volume":"180","author":"WE Carson","year":"1994","unstructured":"Carson, W. E. et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180 (4), 1395\u20131403 (1994).","journal-title":"J. Exp. Med."},{"issue":"6","key":"98367_CR42","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/infdis\/jiaa173","volume":"222","author":"S Suliman","year":"2020","unstructured":"Suliman, S. et al. Peripheral blood mucosal-associated invariant T cells in tuberculosis patients and healthy Mycobacterium tuberculosis-exposed controls. J. Infect. Dis. 222 (6), 995\u20131007 (2020).","journal-title":"J. Infect. Dis."},{"issue":"10","key":"98367_CR43","doi-asserted-by":"publisher","first-page":"6852","DOI":"10.4049\/jimmunol.175.10.6852","volume":"175","author":"P Schierloh","year":"2005","unstructured":"Schierloh, P. et al. Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-gamma-producing CD56bright cells in tuberculous pleurisy. J. Immunol. 175 (10), 6852\u20136860 (2005).","journal-title":"J. Immunol."},{"issue":"1","key":"98367_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/cyto.990220103","volume":"22","author":"B Lucia","year":"1995","unstructured":"Lucia, B. et al. Evidence of a selective depletion of a CD16+CD56+CD8+ natural killer cell subset during HIV infection. Cytometry 22 (1), 10\u201315 (1995).","journal-title":"Cytometry"},{"issue":"9","key":"98367_CR45","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1083\/jcb.201712085","volume":"217","author":"K Srpan","year":"2018","unstructured":"Srpan, K. et al. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells. J. Cell. Biol. 217 (9), 3267\u20133283 (2018).","journal-title":"J. Cell. Biol."},{"key":"98367_CR46","doi-asserted-by":"publisher","first-page":"884648","DOI":"10.3389\/fimmu.2022.884648","volume":"13","author":"I Terren","year":"2022","unstructured":"Terren, I. et al. Cytokine-induced memory-like NK cells: From the basics to clinical applications. Front. Immunol. 13, 884648 (2022).","journal-title":"Front. Immunol."},{"key":"98367_CR47","doi-asserted-by":"crossref","unstructured":"Brownlie, D. et al. Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood. Proc. Natl. Acad. Sci. U S A 118 (11) (2021).","DOI":"10.1073\/pnas.2016580118"},{"key":"98367_CR48","doi-asserted-by":"crossref","unstructured":"Nikzad, R. et al. Human natural killer cells mediate adaptive immunity to viral antigens. Sci. Immunol. 4 (35) (2019).","DOI":"10.1126\/sciimmunol.aat8116"},{"issue":"6","key":"98367_CR49","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.immuni.2019.04.009","volume":"50","author":"NM Adams","year":"2019","unstructured":"Adams, N. M. et al. Cytomegalovirus infection drives avidity selection of natural killer cells. Immunity 50 (6), 1381\u20131390 (2019). e5.","journal-title":"Immunity"},{"issue":"4","key":"98367_CR50","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.4049\/jimmunol.1501996","volume":"197","author":"S Suliman","year":"2016","unstructured":"Suliman, S. et al. Bacillus Calmette-Gu\u00e9rin (BCG) revaccination of adults with latent Mycobacterium tuberculosis infection induces long-lived BCG-reactive NK cell responses. J. Immunol. 197 (4), 1100\u20131110 (2016).","journal-title":"J. Immunol."},{"key":"98367_CR51","doi-asserted-by":"crossref","unstructured":"Van Der Ploeg, K. et al. Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T cell recovery following allogeneic HCT. Blood Adv. (2023).","DOI":"10.1182\/bloodadvances.2022008952"},{"issue":"1","key":"98367_CR52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41467-020-20594-2","volume":"12","author":"EF McKinney","year":"2021","unstructured":"McKinney, E. F. et al. A CD8(+) NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis. Nat. Commun. 12 (1), 635 (2021).","journal-title":"Nat. Commun."},{"issue":"3","key":"98367_CR53","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2567.2005.02235.x","volume":"116","author":"EG Addison","year":"2005","unstructured":"Addison, E. G. et al. Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology 116 (3), 354\u2013361 (2005).","journal-title":"Immunology"},{"issue":"21","key":"98367_CR54","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.1128\/JVI.01420-14","volume":"88","author":"F Ahmad","year":"2014","unstructured":"Ahmad, F. et al. High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progression. J. Virol. 88 (21), 12397\u201312408 (2014).","journal-title":"J. Virol."},{"issue":"4","key":"98367_CR55","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1046\/j.1365-2141.2002.03495.x","volume":"117","author":"MW Lowdell","year":"2002","unstructured":"Lowdell, M. W. et al. Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. Br. J. Haematol. 117 (4), 821\u2013827 (2002).","journal-title":"Br. J. Haematol."},{"issue":"633","key":"98367_CR56","doi-asserted-by":"publisher","first-page":"eabm1375","DOI":"10.1126\/scitranslmed.abm1375","volume":"14","author":"MM Berrien-Elliott","year":"2022","unstructured":"Berrien-Elliott, M. M. et al. Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia. Sci. Transl. Med. 14 (633), eabm1375 (2022).","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"98367_CR57","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.4049\/jimmunol.0901437","volume":"183","author":"VD Gonzalez","year":"2009","unstructured":"Gonzalez, V. D. et al. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: Correlation with outcome of pegylated IFN-\u03b1 and ribavirin treatment. J. Immunol. 183 (10), 6612\u20136618 (2009).","journal-title":"J. Immunol."},{"issue":"1","key":"98367_CR58","doi-asserted-by":"publisher","first-page":"1893500","DOI":"10.1080\/2162402X.2021.1893500","volume":"10","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. A novel multimeric IL15\/IL15R\u03b1-Fc complex to enhance cancer immunotherapy. Oncoimmunology 10 (1), 1893500 (2021).","journal-title":"Oncoimmunology"},{"issue":"2","key":"98367_CR59","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1182\/blood-2011-05-353789","volume":"119","author":"LJ Walker","year":"2012","unstructured":"Walker, L. J. et al. Human MAIT and CD8alphaalpha cells develop from a pool of type-17 precommitted CD8+ T cells. Blood 119 (2), 422\u2013433 (2012).","journal-title":"Blood"},{"issue":"2","key":"98367_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.immuni.2008.01.005","volume":"28","author":"H Cheroutre","year":"2008","unstructured":"Cheroutre, H. & Lambolez, F. Doubting the TCR coreceptor function of CD8alphaalpha. Immunity 28 (2), 149\u2013159 (2008).","journal-title":"Immunity"},{"issue":"9","key":"98367_CR61","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1292\/jvms.65.995","volume":"65","author":"K Kushima","year":"2003","unstructured":"Kushima, K. et al. Flow cytometric analysis of chicken NK activity and its use on the effect of restraint stress. J. Vet. Med. Sci. 65 (9), 995\u20131000 (2003).","journal-title":"J. Vet. Med. Sci."},{"issue":"1","key":"98367_CR62","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41467-019-08604-4","volume":"10","author":"M Gutierrez-Arcelus","year":"2019","unstructured":"Gutierrez-Arcelus, M. et al. Lymphocyte innateness defined by transcriptional states reflects a balance between proliferation and effector functions. Nat. Commun. 10 (1), 687 (2019).","journal-title":"Nat. Commun."},{"issue":"1","key":"98367_CR63","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1038\/s41467-019-11947-7","volume":"10","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat. Commun. 10 (1), 3931 (2019).","journal-title":"Nat. Commun."},{"key":"98367_CR64","unstructured":"Musvosvi, M. et al. T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection. Nat. Med. (2023)."},{"issue":"11","key":"98367_CR65","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.4049\/jimmunol.1900674","volume":"203","author":"S Suliman","year":"2019","unstructured":"Suliman, S. et al. MR1-independent activation of human mucosal-associated invariant T cells by mycobacteria. J. Immunol. 203 (11), 2917\u20132927 (2019).","journal-title":"J. Immunol."},{"issue":"9","key":"98367_CR66","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41577-019-0174-z","volume":"19","author":"P Andersen","year":"2019","unstructured":"Andersen, P. & Scriba, T. J. Moving tuberculosis vaccines from theory to practice. Nat. Rev. Immunol. 19 (9), 550\u2013562 (2019).","journal-title":"Nat. Rev. Immunol."},{"issue":"7720","key":"98367_CR67","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41586-018-0439-x","volume":"560","author":"R Roy Chowdhury","year":"2018","unstructured":"Roy Chowdhury, R. et al. A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes. Nature 560 (7720), 644\u2013648 (2018).","journal-title":"Nature"},{"issue":"Suppl 1","key":"98367_CR68","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1002\/eji.200737584","volume":"37","author":"D Masopust","year":"2007","unstructured":"Masopust, D. et al. A brief history of CD8 T cells. Eur. J. Immunol. 37 (Suppl 1), S103\u2013S110 (2007).","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"98367_CR69","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/intimm\/8.10.1617","volume":"8","author":"LJ Kieffer","year":"1996","unstructured":"Kieffer, L. J. et al. Human CD8 alpha expression in NK cells but not cytotoxic T cells of Transgenic mice. Int. Immunol. 8 (10), 1617\u20131626 (1996).","journal-title":"Int. Immunol."},{"issue":"2","key":"98367_CR70","doi-asserted-by":"publisher","first-page":"724","DOI":"10.18632\/aging.101774","volume":"11","author":"B Muller-Durovic","year":"2019","unstructured":"Muller-Durovic, B. et al. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 11 (2), 724\u2013740 (2019).","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"98367_CR71","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli, A. et al. CD56bright natural killer (NK) cells: An important NK cell subset. Immunology 126 (4), 458\u2013465 (2009).","journal-title":"Immunology"},{"issue":"11","key":"98367_CR72","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nri1711","volume":"5","author":"AS Fauci","year":"2005","unstructured":"Fauci, A. S., Mavilio, D. & Kottilil, S. NK cells in HIV infection: Paradigm for protection or targets for ambush. Nat. Rev. Immunol. 5 (11), 835\u2013843 (2005).","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"98367_CR73","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.it.2010.08.003","volume":"31","author":"NK Bj\u00f6rkstr\u00f6m","year":"2010","unstructured":"Bj\u00f6rkstr\u00f6m, N. K., Ljunggren, H. G. & Sandberg, J. K. CD56 negative NK cells: Origin, function, and role in chronic viral disease. Trends Immunol. 31 (11), 401\u2013406 (2010).","journal-title":"Trends Immunol."},{"issue":"3","key":"98367_CR74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann, B. & Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5 (3), 215\u2013229 (2005).","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"98367_CR75","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1084\/jem.169.6.2233","volume":"169","author":"LL Lanier","year":"1989","unstructured":"Lanier, L. L. et al. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med. 169 (6), 2233\u20132238 (1989).","journal-title":"J. Exp. Med."},{"issue":"2","key":"98367_CR76","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1399-0039.1990.tb01761.x","volume":"35","author":"LA Terry","year":"1990","unstructured":"Terry, L. A. et al. Differential expression and regulation of the human CD8 alpha and CD8 beta chains. Tissue Antigens 35 (2), 82\u201391 (1990).","journal-title":"Tissue Antigens"},{"issue":"2","key":"98367_CR77","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1365-2567.2005.02147.x","volume":"115","author":"RL Webster","year":"2005","unstructured":"Webster, R. L. & Johnson, R. P. Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology 115 (2), 206\u2013214 (2005).","journal-title":"Immunology"},{"key":"98367_CR78","doi-asserted-by":"crossref","unstructured":"Cubitt, C. C. et al. Induced CD8alpha identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation. J. Clin. Investig. 134 (15) (2024).","DOI":"10.1172\/JCI173602"},{"key":"98367_CR79","doi-asserted-by":"crossref","unstructured":"Geng, J. & Raghavan, M. CD8alphaalpha homodimers function as a coreceptor for KIR3DL1. Proc. Natl. Acad. Sci. USA 116 (36), 17951\u201317956 (2019).","DOI":"10.1073\/pnas.1905943116"},{"issue":"29","key":"98367_CR80","doi-asserted-by":"publisher","first-page":"20891","DOI":"10.18632\/oncotarget.25058","volume":"9","author":"S Schmidt","year":"2018","unstructured":"Schmidt, S. et al. Natural killer cells as a therapeutic tool for infectious diseases\u2014Current status and future perspectives. Oncotarget 9 (29), 20891\u201320907 (2018).","journal-title":"Oncotarget"},{"issue":"12","key":"98367_CR81","doi-asserted-by":"publisher","first-page":"e8257","DOI":"10.1371\/journal.pone.0008257","volume":"4","author":"H del Corral","year":"2009","unstructured":"del Corral, H. et al. IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. PLoS One 4 (12), e8257 (2009).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98367-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:12:57Z","timestamp":1745939577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98367-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98367"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98367-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15095"}}